Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
9.80
+0.25 (2.62%)
At close: Mar 9, 2026, 4:00 PM EDT
9.79
-0.01 (-0.10%)
After-hours: Mar 9, 2026, 7:53 PM EDT

Vir Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Market Capitalization
1,5668391,0111,3533,3695,480
Upgrade
Market Cap Growth
16.04%-17.01%-25.30%-59.83%-38.52%60.63%
Upgrade
Enterprise Value
1,197433209-2161,1544,613
Upgrade
Last Close Price
9.806.037.3410.0625.3141.87
Upgrade
PE Ratio
----6.5310.37
Upgrade
Forward PE
-----18.86
Upgrade
PS Ratio
22.8412.2413.6215.702.095.00
Upgrade
PB Ratio
1.791.100.880.851.623.83
Upgrade
P/TBV Ratio
2.121.130.900.871.663.97
Upgrade
P/FCF Ratio
----2.11-
Upgrade
P/OCF Ratio
----2.03-
Upgrade
EV/Sales Ratio
17.466.312.82-0.714.21
Upgrade
EV/EBITDA Ratio
----1.3710.81
Upgrade
EV/EBIT Ratio
----1.3910.96
Upgrade
EV/FCF Ratio
----0.72-
Upgrade
Debt / Equity Ratio
0.130.130.090.080.060.10
Upgrade
Debt / EBITDA Ratio
----0.150.31
Upgrade
Debt / FCF Ratio
----0.08-
Upgrade
Net Debt / Equity Ratio
-0.48-0.48-0.70-0.88-1.09-0.40
Upgrade
Net Debt / EBITDA Ratio
0.810.811.542.18-2.71-1.34
Upgrade
Net Debt / FCF Ratio
0.930.931.781.75-1.438.22
Upgrade
Asset Turnover
0.060.060.050.040.680.76
Upgrade
Quick Ratio
5.075.077.618.744.764.34
Upgrade
Current Ratio
5.545.548.719.064.934.58
Upgrade
Return on Equity (ROE)
-45.73%-45.73%-38.09%-33.54%29.39%49.20%
Upgrade
Return on Assets (ROA)
-24.36%-24.36%-20.26%-17.50%21.89%18.31%
Upgrade
Return on Invested Capital (ROIC)
-119.11%-126.66%-200.87%-171.32%88.77%
Upgrade
Return on Capital Employed (ROCE)
-51.40%-51.40%-42.00%-37.90%36.40%26.10%
Upgrade
Earnings Yield
-27.97%-52.21%-51.63%-45.45%15.31%9.65%
Upgrade
FCF Yield
-25.32%-47.28%-44.88%-59.14%47.35%-1.27%
Upgrade
Buyback Yield / Dilution
-1.67%-1.67%-1.58%0.50%-1.03%-11.98%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.